Hypoxic Stellate Cells of Pancreatic Cancer Stroma Regulate Extracellular Matrix Fiber Organization and Cancer Cell Motility
Overview
Authors
Affiliations
Desmoplasia and hypoxia in pancreatic cancer mutually affect each other and create a tumor-supportive microenvironment. Here, we show that microenvironment remodeling by hypoxic pancreatic stellate cells (PSCs) promotes cancer cell motility through alteration of extracellular matrix (ECM) fiber architecture. Three-dimensional (3-D) matrices derived from PSCs under hypoxia exhibited highly organized parallel-patterned matrix fibers compared with 3-D matrices derived from PSCs under normoxia, and promoted cancer cell motility by inducing directional migration of cancer cells due to the parallel fiber architecture. Microarray analysis revealed that procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) in PSCs was the gene that potentially regulates ECM fiber architecture under hypoxia. Stromal PLOD2 expression in surgical specimens of pancreatic cancer was confirmed by immunohistochemistry. RNA interference-mediated knockdown of PLOD2 in PSCs blocked parallel fiber architecture of 3-D matrices, leading to decreased directional migration of cancer cells within the matrices. In conclusion, these findings indicate that hypoxia-induced PLOD2 expression in PSCs creates a permissive microenvironment for migration of cancer cells through architectural regulation of stromal ECM in pancreatic cancer.
Abu-Serie M, Gutierrez-Garcia A, Enman M, Vaish U, Fatima H, Dudeja V J Gastroenterol. 2025; .
PMID: 39888413 DOI: 10.1007/s00535-025-02213-3.
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.
Feng Q, Shan X, Yau V, Cai Z, Xie S Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861125 PMC: 11769033. DOI: 10.3390/ph18010062.
PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1.
Yin M, Weng Y, Qi T Mol Med Rep. 2024; 31(1).
PMID: 39513600 PMC: 11576930. DOI: 10.3892/mmr.2024.13388.
Pancreatic stellate cells: Key players in pancreatic health and diseases (Review).
Wang Z, Dong S, Zhou W Mol Med Rep. 2024; 30(1).
PMID: 38695254 PMC: 11082724. DOI: 10.3892/mmr.2024.13233.
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
Mary Joseph A, Al Aiyan A, Al-Ramadi B, Singh S, Kishore U Front Immunol. 2024; 15:1323198.
PMID: 38384463 PMC: 10879611. DOI: 10.3389/fimmu.2024.1323198.